Treatment of Severe Pain in Ebola Virus Disease
Severe pain is a clinically significant feature of Ebola virus disease that requires active, structured pharmacological management. Selecting the appropriate analgesic agent and adapting dosing for patient age and weight are key considerations in the protocol.
Treatment approach
The protocol uses a specific analgesic agent to address severe pain, with distinct dosing guidance for adults and for children over six months of age. The complete regimen — including the agent, dose ranges, route, frequency, and daily ceiling — is in the full structured protocol below.
References
- Adults: 50–100 mg PO/IV every 4–6 hours as needed, daily maximum 400 mg/day.
- Children > 6 months: 1–2 mg/kg every 4–6 hours, maximum 400 mg/day.
View source ↗